The plan term is printed next to the price
This sounds small. It is not. Across this comparison, the most common way a low number misleads is by leaving out what you had to commit to in exchange for it.
Gala states the term beside the figure. The headline rate is calculated on a yearly subscription, and the shorter three-month plan carries a higher rate, and both facts sit on the page rather than in a footnote at checkout.
That makes a Gala figure comparable to another seller's figure in a way that a bare headline is not. It is also the reason the inconsistency below is so frustrating.
Three prices for the same product
Gala's own pages give three different figures for the same compounded GLP-1: the yearly headline rate, a higher rate on a three-month plan, and that same higher rate described elsewhere as all-included.
Two of those are the same number wearing two different explanations, which is the confusing part. One presents it as the price of a shorter commitment. The other presents it as the price of a fuller package.
The figure recorded here is the yearly one, with its term written into the qualifier, because that is the number the site leads with. Ask which of the three applies to the plan you are actually buying, and get the answer before you pay.
The headline is a year of commitment
The lowest advertised rate exists only on a yearly subscription. A reader comparing it against a month-to-month seller is comparing twelve months of commitment against thirty days of it.
The three-month plan is the honest comparison point for most people, and it is meaningfully higher. Use that figure when you put Gala next to a flat-rate competitor, not the headline.
There is no separate membership fee on top. The plan rate is described as all-inclusive, so unlike several sellers here a month is one charge rather than two.
One rate, every dose, either molecule
The compounded plan is priced as a program rather than per drug, and Gala describes it as covering all doses. Titrating up does not move the number.
That is a structure worth understanding, because in most of this category tirzepatide costs materially more than semaglutide. A single program rate spanning both molecules removes the penalty for switching.
It also means the comparison cuts both ways. Against a cheap semaglutide-only seller, Gala looks expensive. Against a tirzepatide rate elsewhere, it looks better. Compare it to the drug you actually intend to take.
What it will not tell you
Gala does not name the compounding pharmacy. Its FAQ says only that it works with a network of pharmacies, which is the standard non-answer in this field.
The brand-name side is better disclosed. A cash price for Ozempic sits on the same page as the compounded plan, so the size of the gap between the two routes is visible before you start an intake.
One product in the main navigation is promoted as coming soon and carries no price at all. Do not plan around it.
Gala GLP-1's published pricing
| Medication | Price | Verified |
|---|---|---|
| Semaglutide (compounded) | $179/moper month calculated on a yearly subscription; the same product is $199 per month on a three-month plan | September 2026source |
| Semaglutide (brand) | $1299/moper month, cash price; insurance may reduce it | September 2026source |
compareglp may earn a commission when a reader signs up with a provider through a link on this site. 4 of the 38 providers reviewed here are paid partners today; the other 34 are not. See how this works.
See Gala GLP-1's current price →Good fit if
- Readers comparing a yearly commitment against a shorter plan who want both terms stated on the page rather than discovered at checkout.
- Patients who expect to titrate up and want a rate that does not climb with the dose.
- Buyers who may switch molecules later and do not want to pay a premium for tirzepatide.
- People who want one all-inclusive charge instead of a medication charge with a membership billed beside it.
Look elsewhere if
- Anyone unwilling to commit to a year. The headline rate exists only on a yearly subscription, and the shorter plan costs more.
- Readers who need the compounding pharmacy named. Gala describes a network without naming a member of it; Direct Meds and CareBareRX both name theirs.
- Buyers who want one figure they can trust on sight. Three different prices for this product appear across Gala's own pages.
- Patients waiting on the oral product promoted in the navigation, which is marked coming soon and has no published price.
How this review was verified
- Read the weight-loss page at its own source URL and logged the compounded plan rate and the brand-name Ozempic cash figure with the date each was read.
- Wrote the plan term into the qualifier on the compounded figure, including the higher rate charged on the shorter plan, so the commitment travels with the number.
- Recorded the brand-name figure as a cash price and noted the seller's own statement that insurance may reduce it, rather than presenting it as a final cost.
- Compared the compounded figure across Gala's own pages and found three different values for the same product, which is reported as a discrepancy instead of averaged or resolved.
- Checked how Gala describes the pharmacy that fills an order. It describes a network and does not name one.